Produced on various dates between 28 December 2011 and 10 May 2012, the products were sold for institutional use in Arizona, California, Colorado, Nevada, Oregon, Utah and Washington.
The problem was discovered during a routine label review by FSIS. This recall has been classified as Class II, which indicates a health hazard situation where there is a remote probability of adverse health consequences from the use of the product.
FSIS and the company have not received any reports of adverse reactions due to consumption of the products. The agency has advised anyone concerned about a reaction to contact a healthcare provider.
